Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Buzz on the Bullboards: Where volatility meets opportunity

It has been a wild ride for markets on Bay Street and Wall Street this week. Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day. It is reporting season for many companies, and Stockhouse users seem...
Jonathon Brown | February 15, 2024 |

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

Next-generation augmented reality wayfinding for the real-world metaverse

Hello and welcome to The Market Herald, I’m Daniella Atkinson, and this is The Topline. ARWay Corporation is engaged in developing and operating the ARway mobile app. ARWay is an all-in-one, no-code, real-world Metaverse creation tool with self-generat...
Daniella Atkinson | December 21, 2022 |

Virtual Healthcare Made Easy. Here’s How.

Mednow Inc. ( TSX-V.MNOW , OTCMKTS: MDNWF , Forum ) is a healthcare technology company offering virtual access with exceptional care. It provides virtual care with convenience and through an interdisciplinary approach to healthcare that is focused on the patient experie...
Dave Jackson | December 7, 2021 |

Functional Foods: The New Multi-Billion Dollar Growth Market

Living and eating healthier isn’t just about improving and enriching our lives, it offers investors – both retail and institutional – immense opportunities. Enter Billy Goat Brands ( CSE.GOAT , Forum ) – a Vancouver BC-based venture capital platform f...
Dave Jackson | September 16, 2021 |

Shaping the Future of Regenerative Medicine Today

(Click image to play video) Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF , Forum ) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The Company’...
Dave Jackson | February 10, 2021 |

International students flocking to this company's education real estate model

(Click image to play video) While many businesses have struggled during the pandemic, there have been some that have prospered, and even increased their business. Vancouver-based, CIBT Education Group Inc. (MBA) ( TSX.MBA , OTCQX: MBAIF , Forum ) is one of t...
Isabella Zavarise | January 26, 2021 |

Delivering AR, the Right Way…and in a Fun Way

(Click image to play video) It’s been a good past 12 months in the technology sector, with year-to-year growth metrics pushing the 14% mark. And one part of the tech space is estimated to top $180 billion by 2025. This is the future of the wo...
Dave Jackson | January 15, 2021 |

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...
Featured Submission | December 14, 2020 |
1 2 3 4